Tutorial Arena
Art Room, Level 4
8:30 AM-6:15 PM |
Most
Distinguished Studies 2010-2011 in the Interventional and Clinical
Cardiology: Meet the Authors and Discuss with the Experts
Co-Sponsored by Clinical Research Center for Ischemic Heart Disease,
The Ministry for Health, Welfare & Family Affairs |
| Imaging and Coronary
Physiology |
| Moderators: William F. Fearon,
Spencer B. King III |
| Panelists:
Takashi Akasaka, Chi Kin Chan, Marco A. Costa, John McB. Hodgson,
Myeong-Ki Hong, Sung Yun Lee, Akiko Maehara, Patrick W. Serruys |
| 8:30 AM |
Incidence, Mechanisms, Predictors,
and Clinical Impact of Acute and Late Stent Malapposition After Primary
Intervention in Patients with Acute Myocardial Infarction: An Intravascular
Ultrasound Substudy of the Harmonizing Outcomes with Revascularization
and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial |
Akiko Maehara |
| 8:40 AM |
Panel Discussion |
|
| 8:50 AM |
Evaluation of the Second Generation of a
Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment
of De Novo Coronary Artery Stenosis: Six-Month Clinical and Imaging
Outcomes  |
Patrick W. Serruys |
| 9:00 AM |
Panel Discussion |
|
| |
|
|
Coronary Revascularization
"Drug-Eluting Stent & High Lisk PCI" |
| Moderators: Bernard Chevalier,
David E. Kandzari |
| Panelists:
Andrejs Erglis, Takeshi Kimura, Chih-Kuan
Liao, Duk-Woo Park, Alan C. Yeung |
| 9:10 AM |
Everolimus-Eluting versus Paclitaxel-Eluting
Stents in Coronary Artery Disease (SPIRIT IV) |
Gregg W. Stone |
| 9:20 AM |
Panel Discussion |
|
| 9:30 AM |
Comparison of Zotarolimus-Eluting and Everolimus-Eluting
Coronary Stents |
Patrick W. Serruys |
| 9:40 AM |
Panel Discussion |
|
| 9:50 AM |
Comparisons of Baseline Demographics, Clinical
Presentation, and Long-Term Outcome Among Patients With Early, Late,
and Very Late Stent Thrombosis of Sirolimus-Eluting Stents Observations
From the Registry of Stent Thrombosis for Review and Reevaluation
(RESTART) |
Takeshi Kimura |
| 10:00 AM |
Panel Discussion |
|
| 10:10 AM |
Long-Term Outcomes After Stenting Versus
Coronary Artery Bypass Grafting for Unprotected Left Main Coronary
Artery Disease: 10-Year Results of Bare-Metal Stents and 5-Year Results
of Drug-Eluting Stents From the ASAN–MAIN (ASAN Medical Center–Left
MAIN Revascularization) Registry |
Duk-Woo Park |
| 10:20 AM |
Panel Discussion |
|
| 10:30 AM |
Sirolimus-Eluting Stent versus Balloon Angioplasty
for Sirolimus-Eluting Stent Restenosis: Insights From the J-Cypher
Registry |
Takeshi Kimura |
| 10:40 AM |
Panel Discussion |
|
| |
|
|
Antithrombotic and
Antiplatelet Therapy
"2C19 Polymorphism" |
| Moderators: Duk-Woo Park,
Matthew Price |
| Panelists:
Alaide Chieffo, David J. Cohen, Takaaki Isshiki, Sang Gon Lee, Guillaume
Pare, Kyung Woo Park, Marc S. Sabatine |
| 10:50 AM |
Effects of CYP2C19 Genotype on Outcomes
of Clopidogrel Treatment |
Guillaume Pare |
| 11:00 AM |
Panel Discussion |
|
| 11:10 AM |
[Web-based Lecture] Reduced-Function
CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients
Treated With Clopidogrel Predominantly for PCI: Meta-anlysis |
Marc S. Sabatine |
| 11:20 AM |
Panel Discussion |
|
| |
|
|
| Endovascular Intervention
& Structural Heart Disease |
| Moderators: Richard R. Heuser,
Horst Sievert |
| Panelists:
Ted Feldman, Jacques J. Koolen, Martin B. Leon, Pil-Ki
Min |
| 11:30 AM |
Long-Term Outcome of Open or Endovascular
Repair of Abdominal Aortic Aneurysm (DREAM Trial) |
Philippe Cuypers |
| 11:40 AM |
Panel Discussion |
|
| 11:50 AM |
Transcatheter Aortic-Valve Implantation
for Aortic Stenosis in Patients Who Cannot Undergo Surgery |
Martin B. Leon |
| 12:00 AM |
Panel Discussion |
|
| 12:10 PM |
Adjourn |
|
| |
|
|
| 12:30 PM |
Lunchtime
Activities |
|
| |
|
|
| Imaging
Workshop |
| Invasive Imaging |
| |
PART
I: Decision Making by IVUS and FFR |
| |
Moderators: William F. Fearon,
Gary S. Mintz |
| |
Panelists:
Junbo Ge, Jung-Ho Heo, John McB. Hodgson, Amin Ariff Nuruddin, Nobuhiro Tanaka, Yukio Tsurumi, Takafumi Ueno |
| 2:00 PM |
FFR Clinical Trials and Applications: Make
the PCI Practice Changed |
William F. Fearon |
| 2:12 PM |
Long and Tandem Lesion Intervention: FFR Guided Spot Stenting |
Seung-Jung Park |
| 2:24 PM |
Anatomic and Physiologic Asssessment of
Side Branch Lesions |
John McB. Hodgson |
| 2:36 PM |
Pre- and Post- Stenitng IVUS Assessment
of LM Bifurcation |
Soo-Jin Kang |
| 2:48 PM |
Assessment of DES Failure Using IVUS |
Gary S. Mintz |
| 3:00 PM |
Discussion |
|
| |
|
|
| |
PART
II: Vulnerable Plaque - Identification and Natural History |
| |
Moderators: Takashi Akasaka,
Ik-Kyung Jang |
| |
Panelists:
So-Yeon Choi, Young Joon Hong, Seung-Ho Hur, Akiko Maehara, M Pauliina
Margolis, Eun-Seok Shin |
| 3:10 PM |
Lessons from PROSPECT and FAME: How Do We
Apply Them to Clinical Practice ? |
James R. Margolis |
| 3:22 PM |
Vulnerable Plaque: Lessons from PROSPECT
for Next Generation Imaging Studies |
Akiko Maehara |
| 3:34 PM |
Procession and Regression of Atherosclerosis
Assessed by OCT: Effect of Statin on TCFA |
Takashi Akasaka |
| 3:46 PM |
OCT Clinical Trials and Applications: What Have We Learned So Far? |
Marco A. Costa |
| 3:58 PM |
Discussion |
|
| |
|
|
| |
PART
III: OCT Focusing on DES Failure |
| |
Moderators: Marco A. Costa,
Myeong-Ki Hong |
| |
Panelists:
Kenichi Fujii, Soo-Jin Kang, Chong-Jin Kim, Hironori Kitabata, Jun-ichi
Kotani, Takashi Kubo, Yukio Ozaki, Yasunori Ueda |
| 4:08 PM |
Risk of Stent Thrombosis: Angioscopic Viewpoint |
Yasunori Ueda |
| 4:20 PM |
Late Stent Malapposition / Stent Coverage in DES |
Ik-Kyung Jang |
| 4:32 PM |
Long-Term OCT and VH-IVUS Follow-Up of BMS
and DES: Neoatherosclerosis of In-Stent Neointima |
Soo-Jin Kang |
| 4:44 PM |
Evaluation and Prediction of Late and Very
Late Stent Thrombosis by IVUS and OCT |
Myeong-Ki Hong |
| 4:56 PM |
[Web-based Lecture] Stented Lesion Assessment: Insights from Pathology to OCT |
Renu Virmani |
| 5:08 PM |
Discussion |
|
| |
|
|
| Non-invasive Imaging
for Interventional Cardiologists |
| Moderators: James K. Min,
Wm. Guy Weigold |
| Panelists:
Yeon Hyeon Choe, Jin Ho Choi, Howard A. Cohen, Joon-Won Kang, Samir
Kapadia, Won-Jang Kim, Tae-Hwan Lim |
| 5:18 PM |
For the CTO Intervention: Beyond Diagnosis
and Treatment |
Wm. Guy Weigold |
| 5:30 PM |
CT for Determining Lesion-Specific Ischemia:
Role of Computed FFR |
James K. Min |
| 5:42 PM |
Useful Imaging for Planning and Implementation
of Structural Heart Disease Intervention: ASD, VSD, PFO, and TAVI |
Samir Kapadia |
| 5:54 PM |
4D CT Reconstruction for Planning and Implementation
of Structural Heart Disease Intervention |
Howard A. Cohen |
| 6:06 PM |
Panel Discussion |
|
| |
|
|
| 6:15 PM |
Adjourn |
|
Tutorial Arena
